Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: blood loss (228), haemorrhage (88), flow (240)

Vinorelbine Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER VINORELBINE (INTRAVENOUS) Regimen Breast Cancer – Vinorelbine Indication Treatment of locally advanced or metastatic breast cancer that has
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Vinorelbine-Ver-1.1.pdf

Vinorelbine PO (day 1, 8, 15) Ver 1.2

Description: Chemotherapy Protocol BREAST CANCER VINORELBINE Oral (Day 1, 8, 15) Regimen Breast Cancer – Vinorelbine Oral (day 1, 8, 15) Indication Treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Vinorelbine-PO-day-1-8-15-Ver-1.2.pdf

Paclitaxel Albumin Bound (Abraxane)

Description: Chemotherapy Protocol BREAST CANCER PACLITAXEL ALBUMIN BOUND Regimen • Breast Cancer – Paclitaxel Albumin Bound Indication • Paclitaxel albumin bound can be prescribed where
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Paclitaxel-Albumin-Bound-Abraxane.pdf

Paclitaxel (21 day)

Description: Chemotherapy Protocol BREAST CANCER PACLITAXEL (21day) Regimen • Breast Cancer – Paclitaxel (21day) Indication • Treatment of locally advanced or metastatic breast cancer that
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Paclitaxel-21-day.pdf

Kadcyla (Trastuzumab emtansine) v1

Description: Chemotherapy Protocol BREAST CANCER KADCYLA (trastuzumab emtansine) Kadcyla (trastuzumab emtansine) is NOT the same drug as Herceptin (trastuzumab). There is considerable
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Kadcyla-Trastuzumab-emtansine-v1.pdf

Everolimus-Exemestane

Description: Regimen Chemotherapy Protocol BREAST CANCER EVEROLIMUS and EXEMESTANE • Breast Cancer – Everolimus-Exemestane Indication • The first or second line treatment of post
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Everolimus-Exemestane.pdf

Docetaxel (75) Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER DOCETAXEL (75) Regimen Breast Cancer – Docetaxel (75) Indication Treatment of locally advanced or metastatic HER2 positive breast
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Docetaxel-75-Ver-11.pdf

Cyclophosphamide-Epirubicin-Paclitaxel(7 day)

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXEL (7 day) Regimen • Breast Cancer – Cyclophosphamide-Epirubicin-Paclitaxel (7 day) Indication • Neoadjuvant / adjuvant therapy
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Epirubicin-Paclitaxel-7-day.pdf

Cyclophosphamide-Epirubicin (75)-Fluorouracil (FE75C)

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN (75)- FLUOROURACIL Regimen (FE75C) • Breast Cancer – Cyclophosphamide-Epirubicin (75)-Fluorouracil (FE75C) Indication • Neo-adjuvant / adjuvant
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/FE75C.pdf

Cyclophosphamide-Epirubicin (60)-Fluorouracil (FE60C)

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN (60)- FLUOROURACIL Regimen (FE60C) • Breast Cancer – Cyclophosphamide-Epirubicin (60)-Fluorouracil (FE60C) Indication • Metastatic breast cancer
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/FE60C.pdf

341 to 350 of 706

Previous … 33 34 35 36 37 … Next